| Literature DB >> 32591902 |
Stefano Paolo Zanetti1, Elena Lievore2, Matteo Fontana2, Matteo Turetti2, Andrea Gallioli2, Fabrizio Longo2, Giancarlo Albo3, Elisa De Lorenzis3, Emanuele Montanari3.
Abstract
PURPOSE: To describe the vacuum-assisted mini-percutaneous nephrolithotomy (vmPCNL) technique performed via the 16Ch ClearPetra sheath, to evaluate its outcomes and to analyze intrarenal pressure (IRP) fluctuations during surgery.Entities:
Keywords: Endourology; Intrarenal pressure; Percutaneous nephrolithotomy; Urolithiasis; Vacuum-assisted mini-PCNL
Year: 2020 PMID: 32591902 PMCID: PMC8217021 DOI: 10.1007/s00345-020-03318-5
Source DB: PubMed Journal: World J Urol ISSN: 0724-4983 Impact factor: 4.226
Fig. 1a The ClearPetra set (Well Lead Medical Co., Ltd., China) is composed of a Y-shaped nephrostomic sheath connected, by means of an aspiration tube, to a stone collection bottle (200 ml), which is in turn linked to the central vacuum system. b A valve on the stone collection bottle regulates the aspiration pressure. c A vent on the lateral arm of the sheath can be closed with a finger to increase aspiration pressure during lapaxy. In the meantime the nephroscope d is slowly drawn back until the red stripe on the sheath, thus allowing fragments to fall in the lateral arm of the sheath and in the stone collection bottle
Patients’ and stones’ baseline characteristics
| Total: 122 | |
|---|---|
| Sex, | |
| Male | 74 (60.6) |
| Female | 48 (39.4) |
| Mean age (± SD), years | 55.2 ( |
| BMI, | |
| < 18.5 | 5 (4.1) |
| 18.5–24.9 | 60 (49.2) |
| 25–29.9 | 47 (38.5) |
| ≥ 30 | 10 (8.2) |
| Comorbidities, | |
| Diabetes | 17 (13.9) |
| Hypertension | 32 (26.2) |
| Cardiovascular disease | 12 (9.8) |
| Chronic kidney disease | 3 (2.5) |
| Inflammatory bowel disease | 5 (4.1) |
| Hyperparathyroidism | 3 (2.5) |
| Haemorrhagic diathesis | 2 (1.6) |
| Recurrent urinary tract infections | 22 (18.3) |
| Drugs, | |
| Anticoagulants | 4 (3.3) |
| Antiplatelets | 16 (13.1) |
| American Society of Anesthesiologists score, | |
| 1 | 22 (18) |
| 2 | 79 (64,8) |
| 3 | 21 (17.2) |
| Charlson Comorbidity Index, | |
| 0 | 88 (72.1) |
| 1 | 19 (15.6) |
| 2 | 8 (6.5) |
| 3 | 3 (2.5) |
| 4 | 3 (2.5) |
| 5 | 1 (0.8) |
| Urinary tract abnormalities, | 6 (4,9) |
| Renal malrotation | 2 (1.6) |
| Horseshoe kidney | 1 (0.8) |
| Ectopic kidney | 1 (0.8) |
| Duplex ureter | 2 (1.6) |
| Single kidney, | 3 (2.5) |
| Skeletal abnormalities, | 2 (1.6) |
| Previous homolateral stone treatment, | 61 (50) |
| Stone number, | |
| Single | 48 (39.3) |
| Multiple | 74 (60.7) |
| Median total stone volume (IQR), cm3 | 1.92 (1–3.1) |
| Median mean stone density (IQR), HU | 850 (550–998) |
| Stone location, | |
| Lower calyx | 15 (12.3) |
| Middle calyx | 6 (4.9) |
| Renal pelvis | 24 (19.6) |
| Upper calyx | 4 (3.3) |
| Multiple locations | 73 (59.9) |
| Pre-operative positive urine culture, | 19 (15.6) |
| Stone composition, | |
| Calcium Oxalate Monohydrate | 38 (31.1) |
| Calcium Oxalate Dihydrate | 26 (21.3) |
| Uric acid | 25 (20.5) |
| Calcium Carbonate + Calcium Oxalate | 10 (8.2) |
| Calcium Carbonate | 7 (5.7) |
| Calcium Oxalate Mono + Dihydrate | 5 (4.1) |
| Calcium Phosphate | 4 (3.3) |
| Cystine | 4 (3.3) |
| Struvite | 3 (2.5) |
Surgery-related variables and post-operative outcomes
| 2a. Surgery-related variables | |
|---|---|
| Total: 122 | |
| Laterality | |
| Right | 55 (45.1) |
| Left | 67 (54.9) |
| Access tract number, | |
| Single | 111 (91) |
| Multiple | 11 (9) |
| Access tract location, | |
| Lower calix | 84 (68.8) |
| Middle calix | 20 (16.4) |
| Upper calix | 9 (7.4) |
| Multiple locations | 9 (7.4) |
| Median total laser energy (IQR), kJ | 8.63 (3,75–16,23) |
| Lapaxy modality, | |
| Clear Petra Suction | 78 (63.9) |
| Clear Petra Suction + basket | 44 (36.1) |
| Exit strategy, | |
| Nephrostomy | 97 (79.5) |
| Ureteric catheter/JJ stent | 5 (4.1) |
| Nephrostomy + Ureteric catheter /JJ stent | 20 (16.4) |
| Intra-operative complications, | |
| Contrast medium blow-out | 2 (1.6) |
| Median operative time (IQR), minutes | 90 (71–120) |
| Median lithotripsy + lapaxy time (IQR), minutes | 28 (17–45) |
Intrarenal pressures characteristics and fluctuations
| 3a. IRP characteristics and profile | ||
|---|---|---|
| Mean basic IRP (± SD), cmH2O | 13.19 (± 5.99) | |
| Mean of the mean IRPs during the operations (± SD), cmH2O | 15.38 (± 6.24) | |
| 19 (86) | ||
| N. of cases with mean IRP > 27.19 cmH2O (20 mmHg), | 0 (0) | |
| Median accumulative time with IRP > 40.78 cmH2O (30 mmHg) (IQR), s | 28.52 (12.5 – 60.04) | |
| N. of cases with accumulative time (with IRP > 40.78 cmH2O) > 50 s, | 7 (31.8) | |
| N. of cases with accumulative time (with IRP > 40.78 cmH2O) > 60 s, | 5 (22.7) | |
| N. of cases with accumulative time (with IRP > 40.78 cmH2O) > 70 s, | 3 (13.6) | |
aIntended as the mean of the values of the single procedures for the specific surgical step
bIntended as the maximum value reached among the different procedures for the specific surgical step